Lipopolysaccharide-binding protein in noninfected neonates and those with suspected early-onset bacterial infection

J Perinatol. 2006 Feb;26(2):115-9. doi: 10.1038/sj.jp.7211422.

Abstract

Objectives: To investigate postnatal lipopolysaccharide-binding protein (LBP) kinetics in term neonates and to test its diagnostic accuracy for early-onset bacterial infection (EOBI).

Study design: A total of 99 neonates with clinical and serological signs of EOBI comprised the study group; 198 neonates with risk factors, but without EOBI, served as controls. LBP, C-reactive protein (CRP) and interleukin-8 (IL-8) were determined.

Results: LBP in the noninfected group increased until 24 h after birth (P < 0.05 vs 6 h). LBP and CRP correlated strongly in neonates with suspected EOBI (r = 0.63). Although LBP reached a higher sensitivity than CRP 6 and 12 h after clinical suspicion (45 (24-68) and 79% (54-94) vs 9 (0-24) and 39% (17-64); P < 0.05)), EOBI was most reliably detected by IL-8.

Conclusion: LBP kinetics were age-dependent. LBP was not sufficiently sensitive in the prediction of EOBI.

MeSH terms

  • Acute-Phase Proteins / analysis
  • Acute-Phase Proteins / metabolism*
  • Bacterial Infections / diagnosis*
  • Bacterial Infections / microbiology
  • Biomarkers / analysis
  • C-Reactive Protein / analysis
  • C-Reactive Protein / metabolism*
  • Carrier Proteins / analysis
  • Carrier Proteins / metabolism*
  • Case-Control Studies
  • Cohort Studies
  • Confidence Intervals
  • Early Diagnosis
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Interleukin-8 / analysis
  • Interleukin-8 / metabolism*
  • Male
  • Membrane Glycoproteins / analysis
  • Membrane Glycoproteins / metabolism*
  • Predictive Value of Tests
  • Probability
  • ROC Curve
  • Reference Values
  • Risk Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index

Substances

  • Acute-Phase Proteins
  • Biomarkers
  • Carrier Proteins
  • Interleukin-8
  • Membrane Glycoproteins
  • lipopolysaccharide-binding protein
  • C-Reactive Protein